Scientists have designed a clever molecular barrier that targets the root cause of cell damage rather than just managing the visible symptoms. This discovery offers a hopeful new strategy for halting the spread of the condition within the brain.
SK-129 works by latching onto alpha-synuclein proteins to prevent them from misfolding and sticking together like falling dominoes.
The molecule is small enough to cross the brain’s protective borders and remains active for several days to provide ongoing protection.
In laboratory tests, it successfully shielded dopamine-producing neurons and prevented!! 
.
.
.
